892 related articles for article (PubMed ID: 27421051)
1. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
Boyer S; Iwuji C; Gosset A; Protopopescu C; Okesola N; Plazy M; Spire B; Orne-Gliemann J; McGrath N; Pillay D; Dabis F; Larmarange J;
AIDS Care; 2016; 28 Suppl 3(Suppl 3):39-51. PubMed ID: 27421051
[TBL] [Abstract][Full Text] [Related]
2. Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial.
Iwuji CC; Orne-Gliemann J; Larmarange J; Okesola N; Tanser F; Thiebaut R; Rekacewicz C; Newell ML; Dabis F;
PLoS Med; 2016 Aug; 13(8):e1002107. PubMed ID: 27504637
[TBL] [Abstract][Full Text] [Related]
3. Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial.
Iwuji C; McGrath N; Calmy A; Dabis F; Pillay D; Newell ML; Baisley K; Porter K
J Int AIDS Soc; 2018 Jun; 21(6):e25112. PubMed ID: 29890048
[TBL] [Abstract][Full Text] [Related]
4. Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa.
Larmarange J; Diallo MH; McGrath N; Iwuji C; Plazy M; Thiébaut R; Tanser F; Bärnighausen T; Orne-Gliemann J; Pillay D; Dabis F;
J Int AIDS Soc; 2019 Oct; 22(10):e25402. PubMed ID: 31637821
[TBL] [Abstract][Full Text] [Related]
5. Impact of the test and treat policy on delays in antiretroviral therapy initiation among adult HIV positive patients from six clinics in Johannesburg, South Africa: results from a prospective cohort study.
Onoya D; Sineke T; Hendrickson C; Mokhele I; Maskew M; Long LC; Fox M
BMJ Open; 2020 Mar; 10(3):e030228. PubMed ID: 32213514
[TBL] [Abstract][Full Text] [Related]
6. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
[TBL] [Abstract][Full Text] [Related]
7. Early ART Initiation Improves HIV Status Disclosure and Social Support in People Living with HIV, Linked to Care Within a Universal Test and Treat Program in Rural South Africa (ANRS 12249 TasP Trial).
Fiorentino M; Nishimwe M; Protopopescu C; Iwuji C; Okesola N; Spire B; Orne-Gliemann J; McGrath N; Pillay D; Dabis F; Larmarange J; Boyer S;
AIDS Behav; 2021 Apr; 25(4):1306-1322. PubMed ID: 33206263
[TBL] [Abstract][Full Text] [Related]
8. Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
Rosen S; Maskew M; Fox MP; Nyoni C; Mongwenyana C; Malete G; Sanne I; Bokaba D; Sauls C; Rohr J; Long L
PLoS Med; 2016 May; 13(5):e1002015. PubMed ID: 27163694
[TBL] [Abstract][Full Text] [Related]
9. Change of treatment guidelines and evolution of ART initiation in rural South Africa: data of a large HIV care and treatment programme.
Plazy M; Dabis F; Naidu K; Orne-Gliemann J; Barnighausen T; Dray-Spira R
BMC Infect Dis; 2015 Oct; 15():452. PubMed ID: 26497054
[TBL] [Abstract][Full Text] [Related]
10. Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal.
Orne-Gliemann J; Larmarange J; Boyer S; Iwuji C; McGrath N; Bärnighausen T; Zuma T; Dray-Spira R; Spire B; Rochat T; Lert F; Imrie J;
BMC Public Health; 2015 Mar; 15():209. PubMed ID: 25880823
[TBL] [Abstract][Full Text] [Related]
11. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial.
Iwuji CC; Orne-Gliemann J; Larmarange J; Balestre E; Thiebaut R; Tanser F; Okesola N; Makowa T; Dreyer J; Herbst K; McGrath N; Bärnighausen T; Boyer S; De Oliveira T; Rekacewicz C; Bazin B; Newell ML; Pillay D; Dabis F;
Lancet HIV; 2018 Mar; 5(3):e116-e125. PubMed ID: 29199100
[TBL] [Abstract][Full Text] [Related]
12. The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa).
Larmarange J; Diallo MH; McGrath N; Iwuji C; Plazy M; Thiébaut R; Tanser F; Bärnighausen T; Pillay D; Dabis F; Orne-Gliemann J;
J Int AIDS Soc; 2018 Jul; 21 Suppl 4(Suppl Suppl 4):e25128. PubMed ID: 30027600
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial.
Iwuji CC; Orne-Gliemann J; Tanser F; Boyer S; Lessells RJ; Lert F; Imrie J; Bärnighausen T; Rekacewicz C; Bazin B; Newell ML; Dabis F;
Trials; 2013 Jul; 14():230. PubMed ID: 23880306
[TBL] [Abstract][Full Text] [Related]
14. Retention in Care Trajectories of HIV-Positive Individuals Participating in a Universal Test-and-Treat Program in Rural South Africa (ANRS 12249 TasP Trial).
Gosset A; Protopopescu C; Larmarange J; Orne-Gliemann J; McGrath N; Pillay D; Dabis F; Iwuji C; Boyer S
J Acquir Immune Defic Syndr; 2019 Apr; 80(4):375-385. PubMed ID: 30570525
[TBL] [Abstract][Full Text] [Related]
15. Timing and Predictors of Initiation on Antiretroviral Therapy Among Newly-Diagnosed HIV-Infected Persons in South Africa.
Larsen A; Cheyip M; Tesfay A; Vranken P; Fomundam H; Wutoh A; Aynalem G
AIDS Behav; 2019 Feb; 23(2):375-385. PubMed ID: 30008050
[TBL] [Abstract][Full Text] [Related]
16. Universal test-and-treat in Zambian and South African correctional facilities: a multisite prospective cohort study.
Herce ME; Hoffmann CJ; Fielding K; Topp SM; Hausler H; Chimoyi L; Smith HJ; Chetty-Makkan CM; Mukora R; Tlali M; Olivier AJ; Muyoyeta M; Reid SE; Charalambous S
Lancet HIV; 2020 Dec; 7(12):e807-e816. PubMed ID: 32763152
[TBL] [Abstract][Full Text] [Related]
17. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
[TBL] [Abstract][Full Text] [Related]
18. CD4+ T-Cell Count at Antiretroviral Therapy Initiation in the "Treat-All" Era in Rural South Africa: An Interrupted Time Series Analysis.
Yapa HM; Kim HY; Petoumenos K; Post FA; Jiamsakul A; De Neve JW; Tanser F; Iwuji C; Baisley K; Shahmanesh M; Pillay D; Siedner MJ; Bärnighausen T; Bor J
Clin Infect Dis; 2022 Apr; 74(8):1350-1359. PubMed ID: 34309633
[TBL] [Abstract][Full Text] [Related]
19. Access to HIV care in the context of universal test and treat: challenges within the ANRS 12249 TasP cluster-randomized trial in rural South Africa.
Plazy M; Farouki KE; Iwuji C; Okesola N; Orne-Gliemann J; Larmarange J; Lert F; Newell ML; Dabis F; Dray-Spira R;
J Int AIDS Soc; 2016; 19(1):20913. PubMed ID: 27258430
[TBL] [Abstract][Full Text] [Related]
20. Simplified clinical algorithm for identifying patients eligible for same-day HIV treatment initiation (SLATE): Results from an individually randomized trial in South Africa and Kenya.
Rosen S; Maskew M; Larson BA; Brennan AT; Tsikhutsu I; Fox MP; Vezi L; Bii M; Venter WDF
PLoS Med; 2019 Sep; 16(9):e1002912. PubMed ID: 31525187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
